All News
Filter News
Found 808,690 articles
-
Telemedicine Technologies and Services Market is projected to expand at a CAGR of 15% from 2017 to 2025
7/16/2020
Transparency Market Research has published a new report titled, “Telemedicine Technologies & Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global telemedicine technologies & services market was valued at US$ 21,000 Mn in 2016 and is projected to expand at a CAGR of 15% from 2017 to 2025.
-
Anti-Snoring Devices and Snoring Surgery Market: Increasing Prevalence of Obesity and Sleep Disorders to Rise Demand
7/16/2020
The global anti-snoring devices and snoring surgery market depicts a fragmented competitive landscape.
-
White Biotechnology Market: Biofuel to Continue to Witness High Demand
7/16/2020
The global white biotechnology market is highly consolidated, as key players are holding 71% share in the global market, reports Transparency Market Research.
-
Antithrombin Market: Therapeutics Most Attractive Application Segment
7/16/2020
The global antithrombin market is consolidated in nature with a few small-scale vendors that operate in regional markets and a few large-scale vendors that operate in international markets, states a report by Transparency Market Research.
-
The interim analysis was of a two-dose vaccination schedule given 28 days apart at three different dose levels, 25, 100 and 250 micrograms in 45 healthy adults ranging in age from 18 to 55 years.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.
-
Glympse Bio secured $46.7 million in a Series B fundraising round that will be used to support continued development of the company’s novel biosensor platform in fibrotic diseases such as Non-Alcoholic Steatohepatitis (NASH), oncology, and infectious diseases.
-
Ken Frazier, Merck’s chief executive officer, is reminding the world that vaccine development takes time, typically a decade, and hoping for a viable vaccine against the novel coronavirus by the end of December is premature.
-
FDA Advisory Committee Votes 12-0 to Recommend GSK’s Multiple Myeloma Drug Belantamab Mafodotin
7/15/2020
“We are pleased the committee recognized the potential for belantamab mafodotin to help patients who have relapsed or refractory multiple myeloma, an incurable disease with limited treatment options,” said Axel Hoos, senior vice president and heat of Oncology R&D for GSK. -
Metagenomics can look across the entire genomic sequence of more than 50,000 species of organisms that may be present in a patient sample and compare millions of sequences from a patient with millions of reference sequences.
-
Prior to this raise, according to Crunchbase, the company had raised $114 million.
-
Nanobodies derived from llamas have neutralized the SARS-CoV-2 spike in the lab, effectively neutralizing the virus, according to research from the UK’s Rosalind Franklin Institute.
-
Together, the companies will develop Tumor Treating Fields with Merck’s anti-PD-1 therapy, Keytruda for the treatment of non-small cell lung cancer (NSCLC).
-
While you don’t want to be the person that survived mass layoffs only to turn around and ask for a salary bump for reasons you can probably guess, you also don’t want to be severely underpaid or underappreciated.
-
Compound Derived From Red Algae May Protect Against Nipah Virus
7/15/2020
A “Swiss army knife” protein that is active against several viruses may also offer some protection against Nipah virus, a lethal pathogen with no cure or vaccine.
-
MedX Health Corp. Announces First Quarter 2020 Results
7/15/2020
MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the three-months ended March 31, 2020, which are also available on SEDAR (www.sedar.com).
-
Freenome Holdings, Inc. Chooses SYSPRO ERP to Help Enable Next-Generation Early Cancer Detection
7/15/2020
Innovative biotechnology company to use SYSPRO software to boost growth through AI integrations, advanced reporting, and compliance capabilities
-
MediPines Releases Scientific Paper on COVID-19 Respiratory Monitoring
7/15/2020
In an effort to support healthcare providers facing massive healthcare burdens due to the current respiratory challenges caused by COVID-19, MediPines has released a timely scientific discussion on oxygen saturation versus pulmonary gas exchange as a respiratory monitoring imperative for COVID-19 patients.
-
Technimark Acquires European Injection Molder, Tool & Plastic Industries Ltd., Expanding Global Manufacturing Platform And Healthcare Focus
7/15/2020
Technimark, a global manufacturer of custom rigid plastic packaging and components, announced today it has acquired Tool & Plastic Industries Ltd., a leading supplier of injection molded products for the medical device, pharmaceutical and consumer product sectors.
-
Genetic Technologies Provides Update on COVID-19 Disease Severity Test
7/15/2020
Highlights Genetic Technologies has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in Australia The COVID-19 Severity Risk Test comprises a polygenic risk test (PRS) and assessment for clinical risk factors Genetic Technologies has completed the design and request for initial production of the SNP (Single Nucleotide Polymorphism) panel required to process the polygenic risk test portion of the COVID-19 Severity Risk Test from US-based Thermo Fisher Sc